3 not yet recruiting, 1 recruiting, 1 unknown. 3 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Not yet recruiting 2, Recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Peritoneal Carcinosis: new trials by email Literature Review of Peritoneal Carcinosis trials Research Report on Peritoneal Carcinosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Paricalcitol Versus Pirfenidone for Improving Surgical Resectability in Patients With Peritoneal Cancer Paricalcitol, pirfenidone - Peritoneal (Metastatic) Cancer, Peritoneal Carcinoma | Phase 2 | Not yet recruiting | Patrick Wagner, MD, FACS | 74 | 2026-09-01 | 2026-10-05 |
| Impact of an Omega-3 Enriched Oral Nutritional Supplement on Improving Surgical Outcomes in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery ONS enriched with Omega-3, Standard ONS - Peritoneal Carcinosis, Peritoneal Metastases | Not applicable | Not yet recruiting | Catholic University of the Sacred Heart | 28 | 2026-04-01 | 2026-03-17 |
| PONDER: Pelvic Peritonectomy in Early Stage Ovarian Tumors systematic surgical approach to wider peritoneal biopsies according with dissection of retroperitoneal spaces, nerve-sparing approach, Histopathologic Analysis - Early Stage Ovarian Tumors, Peritoneal Carcinosis | Not applicable | Not yet recruiting | Ospedale Santa Croce-Carle Cuneo | 390 | 2026-02-01 | 2025-12-09 |
| Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE) biological collection, Tissues collections - Cancer, Peritoneal Carcinosis | Not applicable | Recruiting | Institut du Cancer de Montpellier - Val d'Aurelle | 600 | 2019-11-25 | 2025-02-12 |
| Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis intraperitoneal (IP) OXAliplatin (OXA) + systemic FOLFIRI bevacizumab chemotherapy - Peritoneal Carcinosis | Phase 1 / Phase 2 | Unknown | Hospices Civils de Lyon | 47 | 2017-05-18 | 2017-09-21 |
Neoplasms (2) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Peritoneal Neoplasms (1)
Neoplasms by Site (2) · Abdominal Neoplasms (1) · Adnexal Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Neoplasms (1) · Neoplastic Processes (1)
Docosahexaenoic Acids (1) · Infusions, Parenteral (1) · Oxaliplatin (1) · paricalcitol (1) · pirfenidone (1)
Catholic University of the Sacred Heart (1) · Hospices Civils de Lyon (1) · Institut du Cancer de Montpellier - Val d'Aurelle (1) · Ospedale Santa Croce-Carle Cuneo (1) · Patrick Wagner, MD, FACS (1)
France (2) · Italy (2)
Andrea Puppo, MD (1) · Benoit You, MD (1) · Elena Olearo, MD (1) · Patrick Wagner (1)